Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension

Precise quantitation of SMN1 copy number is of great interest in many clinical applications such as direct detection of SMA carriers or detection of an SMA‐affected patient with a hemizygous deletion of the SMN1 gene. We describe a method that combines two independent nonradioactive PCR assays: determination of the relative ratio of the SMN1 and SMN2 genes using a primer extension assay and of the total SMN copy number using competitive PCR. Consistency of the results of two independent approaches ensures the reliability of the deduced genotype and thus avoids false interpretation of borderline results that can occur in quantitative assays. In all, 135 subjects were tested, including 91 normal controls and 44 SMA‐affected children or SMA carriers. Two main genotypes were observed in controls: 2T/2C (45%) and 2T/1C (32%). A wide variability at the SMN locus is observed with nine different genotypes and up to six SMN genes. SMA carriers showed three frequent genotypes, 1T/2C (50%), 1T/3C (29%), and 1T/1C (18%). Normal chromosomes with two SMN1 genes per chromosome are not infrequent and thus, about 3% of SMA carriers are not detected using SMN1 copy number quantitation. Finally, as this method does not detect point mutations (˜4% of SMN1 gene mutations), reliability ranges from 93% to 100% depending on data available from the propositus. Hum Mutat 16:253–263, 2000. © 2000 Wiley‐Liss, Inc.

[1]  B. Wirth.  An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA) , 2000, Human mutation.

[2]  U. Monani,et al.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. , 2000, Human molecular genetics.

[3]  Hung Li,et al.  A mouse model for spinal muscular atrophy , 2000, Nature Genetics.

[4]  T. Wienker,et al.  Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. , 1999, American journal of human genetics.

[5]  D. Parsons,et al.  Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. , 1998, American journal of human genetics.

[6]  A. Quattrone,et al.  Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene , 1998, Annals of neurology.

[7]  C. Lewis,et al.  Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy , 1998, European Journal of Human Genetics.

[8]  J. Melki,et al.  The role of the SMN gene in proximal spinal muscular atrophy. , 1998, Human molecular genetics.

[9]  K. Davies,et al.  Maternal mosaicism for a second mutational event in a type I spinal muscular atrophy family. , 1998, American journal of human genetics.

[10]  B. Wirth,et al.  De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. , 1997, American journal of human genetics.

[11]  B. Wirth,et al.  Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region , 1997, Annals of neurology.

[12]  L. Surh,et al.  Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7 , 1997, Neurogenetics.

[13]  T. Crawford,et al.  The survival motor neuron protein in spinal muscular atrophy. , 1997, Human molecular genetics.

[14]  A. Burghes.  When is a deletion not a deletion? When it is converted. , 1997, American journal of human genetics.

[15]  K. Davies,et al.  Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. , 1997, American journal of human genetics.

[16]  Arnold Munnich,et al.  Correlation between severity and SMN protein level in spinal muscular atrophy , 1997, Nature Genetics.

[17]  J. Mendell,et al.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. , 1997, American journal of human genetics.

[18]  M. Schwartz,et al.  Quantification, by solid-phase minisequencing, of the telomeric and centromeric copies of the survival motor neuron gene in families with spinal muscular atrophy. , 1997, Human molecular genetics.

[19]  K. Devriendt,et al.  Clinical and molecular genetic features of congenital spinal muscular atrophy , 1996, Annals of neurology.

[20]  B. Wirth,et al.  Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease. , 1996, American journal of human genetics.

[21]  D. Parsons,et al.  An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. , 1996, Human molecular genetics.

[22]  J. D. den Dunnen,et al.  Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. , 1996, American journal of human genetics.

[23]  A. Munnich,et al.  Survival motor neuron gene deletion in the arthrogryposis multiplex congenita-spinal muscular atrophy association. , 1996, The Journal of clinical investigation.

[24]  K. Devriendt,et al.  Unusual molecular findings in autosomal recessive spinal muscular atrophy. , 1996, Journal of medical genetics.

[25]  B. Wirth,et al.  Clinical Spectrum and Diagnostic Criteria of Infantile Spinal Muscular Atrophy: Further Delineation on the Basis of SMN Gene Deletion Findings , 1996, Neuropediatrics.

[26]  E. Velasco,et al.  Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. , 1996, Human molecular genetics.

[27]  H. Cavé,et al.  Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias , 1996, British journal of haematology.

[28]  A. Munnich,et al.  A frame–shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients , 1995, Nature Genetics.

[29]  J. Boakes.  False memory syndrome , 1995, The Lancet.

[30]  P. Tonali,et al.  Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy , 1995, The Lancet.

[31]  B. Dallapiccola,et al.  Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. , 1995, Biochemical and biophysical research communications.

[32]  A. Munnich,et al.  SMN gene deletion in variant of infantile spinal muscular atrophy , 1995, The Lancet.

[33]  J. Osinga,et al.  PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy , 1995, The Lancet.

[34]  N. Cross,et al.  Quantitative PCR techniques and applications. , 1995, British journal of haematology.

[35]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[36]  T. Crawford,et al.  The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy , 1995, Cell.

[37]  D. Le Paslier,et al.  De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. , 1994, Science.

[38]  B. Grandchamp,et al.  A simplified method for determination of specific DNA or RNA copy number using quantitative PCR and an automatic DNA sequencer. , 1992, BioTechniques.

[39]  J. Pearn.  CLASSIFICATION OF SPINAL MUSCULAR ATROPHIES , 1980, The Lancet.